Keros Therapeutics Inc. – Material Contracts Watch

from 10-Q 9 pages Executive Employment Agreement

from 10-K 2 pages Amendment to Executive Employment Agreement

from 10-K 9 pages Amendment No. 1 to Exclusive License Agreement

from 10-K 3 pages Keros Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy

from 8-K 9 pages Executive Employment Agreement

from 8-K 13 pages August 6, 2025 Christopher Rovaldi [***]

from 8-K 9 pages Executive Employment Agreement

from 10-Q 2 pages Keros Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy

from 8-K 6 pages 1.director Slate. the Company’s Board of Directors (The “Board”) Shall Take All Necessary Actions to Nominate Mary Ann Gray, Ran Nussbaum and Alpna Seth (The “Director Slate”) for Election to the Board at the 2025 Annual Meeting of Stockholders (The “Annual Meeting”). the Company Will Use Its Commercially Reasonable Efforts (Which Will Include the Solicitation of Proxies) to Obtain the Election of Mr. Nussbaum at the Annual Meeting (For the Avoidance of Doubt, the Company Will Only Be Required to Use Substantially the Same Level of Efforts and Provide Substantially the Same Level of Support as Is Used and/or Provided for the Other Director Nominees of the Company With Respect to the Annual Meeting). 2. Standstill

from 10-K 89 pages Exclusive License Agreement

from 10-K 11 pages Keros Therapeutics, Inc. Stock Option Grant Notice

from 8-K 11 pages Executive Employment Agreement

from 10-Q 2 pages Keros Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy

from 10-K 3 pages Amendment No. 4 to License Agreement

from 10-Q 2 pages Keros Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy

from 10-Q 5 pages First Amendment to Lease

from 10-K 6 pages Amendment No. 2 to License Agreement

from 10-Q 5 pages Jennifer Lachey August 1, 2022

from 10-K 3 pages First Amendment to the Executive Employment Agreement of Simon Cooper

from 10-K 3 pages First Amendment to the Executive Employment Agreement of Keith Regnante